Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Diabetologia|December 1, 2006
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities StudyR C Hoogeveen, C M Ballantyne, H Bang, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Gene targeting yields a CD18-mutant mouse for study of inflammationR W Wilson, C M Ballantyne, C W Smith, et al.Clinical Therapeutics|April 11, 2001
Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysisC M Ballantyne, F Pazzucconi, X Pintó, et al.Atherosclerosis|April 27, 1999
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteinsH J Pownall, D Brauchi, C Kilinç, et al.Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1J E Sligh, C M Ballantyne, S S Rich, et al.The American Journal of Cardiology|February 1, 1991
Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplantF W Smart, C M Ballantyne, B Cocanougher, et al.International Journal of Obesity (2005)|May 28, 2008
Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC studyC M Ballantyne, R C Hoogeveen, A M McNeill, et al.Circulation|January 7, 1998
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyS J Hwang, C M Ballantyne, A R Sharrett, et al.Molecular and Cellular Biochemistry|June 7, 1995
Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardiumG L Kukielka, K A Youker, L H Michael, et al.Journal of the American College of Cardiology|November 18, 2000
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapyC M Ballantyne, J A Herd, E A Stein, et al.Pageof 10